Sign In
Buy OMCL
$41.89
-0.0200 (-0.0477%)
At Close: Jun 03, 2026
Reasons to Add Patterson Companies (PDCO) Stock to Your Portfolio
02:48pm, Wednesday, 18'th May 2022 Zacks Investment Research
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.
AMN Healthcare's (AMN) New Buyout to Aid Healthcare Staffing
02:22pm, Tuesday, 17'th May 2022 Zacks Investment Research
AMN Healthcare's (AMN) acquisition of Connetics USA is expected to significantly boost its Nurse and Allied Solutions segment globally.
Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now
02:48pm, Monday, 16'th May 2022 Zacks Investment Research
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.
Doximity (DOCS) to Report Q4 Earnings: What's in the Offing?
02:30pm, Monday, 16'th May 2022 Zacks Investment Research
Doximity's (DOCS) fiscal fourth-quarter results are likely to reflect continued strength in its telehealth platform.
Inogen (INGN) Stock Inches Up 0.5% Post Q1 Earnings Beat
02:12pm, Friday, 13'th May 2022 Zacks Investment Research
Inogen's (INGN) first-quarter results benefit from higher revenues across the majority of its geographical segments and categories.
OPKO Health (OPK) Post In-Line Q1 Earnings, Revenues Top
03:00pm, Wednesday, 11'th May 2022 Zacks Investment Research
OPKO Health's (OPK) first-quarter results benefit from continued strength in its Pharmaceuticals segment.
Amedisys (AMED) New Buyouts Aid Growth, Margin Pressure Stays
02:07pm, Wednesday, 11'th May 2022 Zacks Investment Research
Amedisys' (AMED) newly-formed high-acuity care segment experiences solid momentum in the first quarter.
Shockwave Medical (SWAV) Beats on Q1 Earnings & Revenues
11:15am, Wednesday, 11'th May 2022 Zacks Investment Research
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and expansion in gross margin.
Allscripts' (MDRX) Stock Falls 8.8% Post Q1 Earnings Miss
03:12pm, Tuesday, 10'th May 2022 Zacks Investment Research
Allscripts' (MDRX) robust Q1 results demonstrate strength in both segments.
Glaukos (GKOS) Stock Falls 25.9% Despite Q1 Earnings Beat
03:04pm, Tuesday, 10'th May 2022 Zacks Investment Research
Glaukos' (GKOS) soft Q1 results fail to impress investors.
Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates
02:44pm, Tuesday, 10'th May 2022 Zacks Investment Research
Fresenius Medical's (FMS) first-quarter earnings benefit from strong performance across all the geographic regions and segments.
DENTSPLY SIRONA (XRAY) Reports Weak Q1 Preliminary Results
02:14pm, Tuesday, 10'th May 2022 Zacks Investment Research
DENTSPLY SIRONA's (XRAY) preliminary first-quarter 2022 results reflect weakness in segments.
Nevro (NVRO) Stock Falls 19% Despite Q1 Earnings Beat
03:15pm, Monday, 09'th May 2022 Zacks Investment Research
Nevro's (NVRO) worldwide revenues fall on a year-over-year basis in Q1 partly due to soft domestic performance.
AMN Healthcare (AMN) Q1 Earnings, Revenues Beat Estimates
02:04pm, Monday, 09'th May 2022 Zacks Investment Research
AMN Healthcare's (AMN) robust Q1 results demonstrate its segmental strength.
McKesson (MCK) Q4 Earnings Miss, Revenues Beat Estimates
04:17pm, Friday, 06'th May 2022 Zacks Investment Research
McKesson's (MCK) fiscal fourth-quarter 2022 results benefit from segmental growth.
